These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22751547)

  • 1. Correlation between fecal concentrations of ciprofloxacin and fecal counts of resistant Enterobacteriaceae in piglets treated with ciprofloxacin: toward new means to control the spread of resistance?
    Nguyen TT; Chachaty E; Huy C; Cambier C; de Gunzburg J; Mentré F; Andremont A
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4973-5. PubMed ID: 22751547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical modeling of bacterial kinetics to predict the impact of antibiotic colonic exposure and treatment duration on the amount of resistant enterobacteria excreted.
    Nguyen TT; Guedj J; Chachaty E; de Gunzburg J; Andremont A; Mentré F
    PLoS Comput Biol; 2014 Sep; 10(9):e1003840. PubMed ID: 25210849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model.
    Perrin-Guyomard A; Poul JM; Corpet DE; Sanders P; Fernández AH; Bartholomew M
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):151-60. PubMed ID: 15963836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in concentrations of fluoroquinolones and of ciprofloxacin-resistant Enterobacteriaceae in chicken feces and manure stored in a heap.
    Moraru R; Pourcher AM; Jadas-Hecart A; Kempf I; Ziebal C; Kervarrec M; Comunal PY; Mares M; Dabert P
    J Environ Qual; 2012; 41(3):754-63. PubMed ID: 22565257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin dosage and emergence of resistance in human commensal bacteria.
    Fantin B; Duval X; Massias L; Alavoine L; Chau F; Retout S; Andremont A; Mentré F
    J Infect Dis; 2009 Aug; 200(3):390-8. PubMed ID: 19563257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Support for higher ciprofloxacin AUC 24/MIC targets in treating Enterobacteriaceae bloodstream infection.
    Zelenitsky SA; Ariano RE
    J Antimicrob Chemother; 2010 Aug; 65(8):1725-32. PubMed ID: 20558470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora.
    Bergan T; Delin C; Johansen S; Kolstad IM; Nord CE; Thorsteinsson SB
    Antimicrob Agents Chemother; 1986 Feb; 29(2):298-302. PubMed ID: 2940965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin-resistant enterobacteria harboring the aac(6')-Ib-cr variant isolated from feces of inpatients in an intensive care unit in Uruguay.
    Cordeiro NF; Robino L; Medina J; Seija V; Bado I; García V; Berro M; Pontet J; López L; Bazet C; Rieppi G; Gutkind G; Ayala JA; Vignoli R
    Antimicrob Agents Chemother; 2008 Feb; 52(2):806-7. PubMed ID: 17999962
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model.
    Perrin-Guyomard A; Poul JM; Laurentie M; Sanders P; Fernández AH; Bartholomew M
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):66-78. PubMed ID: 16563587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of fluoroquinolone resistance amongst commensal flora of antibiotic naïve neonates: a study from India.
    Saksena R; Gaind R; Sinha A; Kothari C; Chellani H; Deb M
    J Med Microbiol; 2018 Apr; 67(4):481-488. PubMed ID: 29458558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the impact of the administration of Amoxicillin and Algo-Bio
    Kouadio IK; Guessennd N; Dadié A; Koffi E; Dosso M
    J Glob Antimicrob Resist; 2018 Jun; 13():161-164. PubMed ID: 29366720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers.
    Pecquet S; Ravoire S; Andremont A
    J Antimicrob Chemother; 1990 Jul; 26(1):125-9. PubMed ID: 2211433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of individual dynamic patterns of emergence of resistance to quinolones in Escherichia coli from the fecal flora of healthy volunteers exposed to ciprofloxacin.
    de Lastours V; Cambau E; Guillard T; Marcade G; Chau F; Fantin B
    J Infect Dis; 2012 Nov; 206(9):1399-406. PubMed ID: 22930806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study on human fecal carriage of Enterobacteriaceae possessing mcr-1 and mcr-2 genes in a regional hospital in Hong Kong.
    Chan WS; Au CH; Ho DN; Chan TL; Ma ES; Tang BS
    BMC Infect Dis; 2018 Feb; 18(1):81. PubMed ID: 29439654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.
    Strukova EN; Portnoy YA; Zinner SH; Firsov AA
    J Antimicrob Chemother; 2016 Mar; 71(3):678-84. PubMed ID: 26626718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of three ampicillin dosage regimens on selection of ampicillin resistance in Enterobacteriaceae and excretion of blaTEM genes in swine feces.
    Bibbal D; Dupouy V; Ferré JP; Toutain PL; Fayet O; Prère MF; Bousquet-Mélou A
    Appl Environ Microbiol; 2007 Aug; 73(15):4785-90. PubMed ID: 17557857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bird-livestock interactions associated with increased cattle fecal shedding of ciprofloxacin-resistant Escherichia coli within feedlots in the United States.
    Carlson JC; Chandler JC; Bisha B; LeJeune JT; Wittum TE
    Sci Rep; 2020 Jun; 10(1):10174. PubMed ID: 32576851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.
    Firsov AA; Smirnova MV; Strukova EN; Vostrov SN; Portnoy YA; Zinner SH
    Int J Antimicrob Agents; 2008 Dec; 32(6):488-93. PubMed ID: 18790614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of fecal Enterobacteriaceae by intravenous ciprofloxacin is not inhibited by concomitant sucralfate--a microbiological and pharmacokinetic study in patients.
    Krueger WA; Ruckdeschel G; Unertl K
    Infection; 1999; 27(6):335-40. PubMed ID: 10624593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India.
    Mittal G; Gaind R; Kumar D; Kaushik G; Gupta KB; Verma PK; Deb M
    BMC Microbiol; 2016 Jul; 16(1):138. PubMed ID: 27392139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.